Gary Sternberg is the founder of Stargazer Pharmaceuticals. Stargazer Pharmaceuticals has raised $57M in total funding. Latest round: Series A.
Gary Sternberg is a co-founder of Stargazer Pharmaceuticals, a biopharmaceutical company focused on developing treatments for rare eye diseases. He serves as the company's Chief Executive Officer and was instrumental in its launch following the licensing of STG-001 from Takeda Pharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library